81 related articles for article (PubMed ID: 22864906)
41. Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin.
Sánchez-Margalet V; González-Yanes C; Najib S; Santos-Alvarez J
Regul Pept; 2010 Apr; 161(1-3):8-14. PubMed ID: 20184923
[TBL] [Abstract][Full Text] [Related]
42. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
43. Gonadotroph cell pituitary adenomas in males.
Manieri C; Di Bisceglie C; Razzore P; Fornengo R; Papotti M; Isolato G; Ciccarelli E
Panminerva Med; 2000 Dec; 42(4):237-40. PubMed ID: 11294084
[TBL] [Abstract][Full Text] [Related]
44. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
45. Nonsecreting pituitary tumors.
Klibanski A
Endocrinol Metab Clin North Am; 1987 Sep; 16(3):793-804. PubMed ID: 3319603
[TBL] [Abstract][Full Text] [Related]
46. [Pancreastatin secretion stimulation in healthy volunteers].
Zagórowicz E; Bak M; Siemińska J; Muszyński J
Pol Arch Med Wewn; 2002 Dec; 108(6):1185-91. PubMed ID: 12687931
[TBL] [Abstract][Full Text] [Related]
47. Serum pancreastatin: the long sought universal, sensitive, specific tumor marker for neuroendocrine tumors?
Ito T; Igarashi H; Jensen RT
Pancreas; 2012 May; 41(4):505-7. PubMed ID: 22504376
[No Abstract] [Full Text] [Related]
48. Unique change of pancreastatin-like immunoreactivity in cerebrospinal fluid by aging.
Sekiya K; Nakao R; Takayanagi R; Haji M; Kurose S; Oyama M; Ohashi M; Tateishi K; Funakoshi A; Akazawa K
Neurosci Lett; 1994 Mar; 170(1):179-82. PubMed ID: 8041502
[TBL] [Abstract][Full Text] [Related]
49. Publisher's Note: Chromogranin A-derived peptides pancreastatin and catestatin: emerging therapeutic target for diabetes.
Amino Acids; 2023 Dec; 55(12):1801. PubMed ID: 38032375
[No Abstract] [Full Text] [Related]
50. Houssay phenomenon in a diabetic.
Drury MI; O'Loughlin S; Sweeney E
Br Med J; 1970 Jun; 2(5711):709. PubMed ID: 5429657
[No Abstract] [Full Text] [Related]
51. Definition of the extracellular space in secreting and nonsecreting oxyntic cells.
Forte TM; Forte JG
J Cell Biol; 1970 Dec; 47(3):782-6. PubMed ID: 5497554
[No Abstract] [Full Text] [Related]
52. [Physiopathology and clinical manifestations of diabetes in the aged].
LANDABURE PB
Dia Med; 1955 Sep; 27(64):2043; passim. PubMed ID: 13365446
[No Abstract] [Full Text] [Related]
53. [Physiopathology and clinical aspects of diabetes in the aged].
LANDABURE PB
Rev Med Cubana; 1956 Apr; 67(4):293-302. PubMed ID: 13336745
[No Abstract] [Full Text] [Related]
54. Case of Diabetes Mellitus, Associated with Lesions of the Pituitary Body.
McPherson E
Glasgow Med J; 1939 May; 131(5):220-224. PubMed ID: 30436149
[No Abstract] [Full Text] [Related]
55. [Physiopathology of diabetes].
HOUSSAY BA
Rev Asoc Med Argent; 1950 Mar 15-30; 64(673-674):105-11. PubMed ID: 15417812
[No Abstract] [Full Text] [Related]
56. A Case of Diabetes Mellitus Apparently Ameliorated or Cured by a Probable Inflammatory Lesion in the Pituitary.
Bowen BD
Trans Am Clin Climatol Assoc; 1946; 58():137-44. PubMed ID: 21407656
[No Abstract] [Full Text] [Related]
57. THE PITUITARY AND DIABETES.
Br Med J; 1938 Nov; 2(4063):1048-9. PubMed ID: 20781898
[No Abstract] [Full Text] [Related]
58. Study of the involvement of pancreastatin in the physiopathology of diabetes mellitus associated with nonsecreting pituitary adenomas.
Prévost G; Eas F; Duparc C; Cauliez B; Laquérrière A; Fréger P; Lefebvre H; Kuhn JM
Horm Metab Res; 2012 Oct; 44(11):861-5. PubMed ID: 22864906
[TBL] [Abstract][Full Text] [Related]
59. Pancreastatin secretion by pituitary adenomas and regulation of chromogranin B mRNA expression.
Jin L; Scheithauer BW; Young WF; Davis DH; Klee GG; Lloyd RV
Am J Pathol; 1996 Jun; 148(6):2057-66. PubMed ID: 8669489
[TBL] [Abstract][Full Text] [Related]
60. Analysis of the chromogranin A post-translational cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries.
Lloyd RV; Jin L; Qian X; Scheithauer BW; Young WF; Davis DH
Am J Pathol; 1995 May; 146(5):1188-98. PubMed ID: 7747813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
